Literature DB >> 19083096

Down-regulation of protein and mRNA expression of IL-8 and ICAM-1 in colon tissue of ulcerative colitis patients by partition-herb moxibustion.

En-Hua Zhou1, Hui-Rong Liu, Huan-Gan Wu, Zheng Shi, Wei Zhang, Yi Zhu, Da-Ren Shi, Shuang Zhou.   

Abstract

Our previous studies have demonstrated the efficacy of partition-herb moxibustion on ulcerative colitis (UC) rats. However, the mechanism of actions of partition-herb moxibustion is still unclear. Most Chinese acupuncturists believe that partition-herb improves the effect of moxibustion therapy. However, this argument lacks confirming experimental and clinical evidence. So, whether partition-herb does play a role in the mechanism of actions of partition-herb moxibustion was reported in this paper. A total of 123 patients were randomly divided into the partition-herb moxibustion group and the control group (partition-bran moxibustion group). Fourteen patients dropped out of the study. Finally, 109 patients finished the intervention. Sixty-one patients with UC received partition-herb moxibustion and 48 patients with UC received partition-bran moxibustion for 72 treatments, one treatment per day, every 12 treatments with an interval of 3 days. The expressions of interleukin-8 (IL-8) and intercellular adhesion molecule-1 (ICAM-1) in the colonic mucosa tissue in mild patients with UC were assayed by immunohistochemistry and RT-PCR. Histology of the colon also was observed at entry and after 72 treatments. Clinical therapeutic effect in partition-herb moxibustion was significantly better than those in partition-bran moxibustion (P < 0.05). Protein and mRNA expression of IL-8, ICAM-1 in the patients was inhibited by both partition-herb moxibustion and partition-bran moxibustion, of those the inhibition in the partition-herb moxibustion group was more obvious (P < 0.01). Partition-herb moxibustion was shown to significantly improve the histology of the colon, and partition-herb was shown to improve the therapeutic effect of moxibustion on treatment of UC patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19083096     DOI: 10.1007/s10620-008-0620-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

2.  Intercellular adhesion molecule-1 (ICAM-1) in ulcerative colitis: presence, visualization, and significance.

Authors:  B Vainer
Journal:  Inflamm Res       Date:  2005-08       Impact factor: 4.575

3.  [Study on differentially expressed genes of ulcerative colitis in the rat treated by herbs-partitioned moxibustion].

Authors:  Huan-Gan Wu; Hui-Rong Liu; Chen Zhao; Wei Zhang; Xue-Fei Wu; Shuang Zhou; Yin Shi; Min Liu
Journal:  Zhongguo Zhen Jiu       Date:  2005-05

4.  American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.

Authors:  Michael Clark; Jean-Frederic Colombel; Brian C Feagan; Richard N Fedorak; Stephen B Hanauer; Michael A Kamm; Lloyd Mayer; Carol Regueiro; Paul Rutgeerts; William J Sandborn; Bruce E Sands; Stefan Schreiber; Stephan Targan; Simon Travis; Severine Vermeire
Journal:  Gastroenterology       Date:  2007-07       Impact factor: 22.682

Review 5.  Role of cytokines in the pathogenesis of inflammatory bowel disease.

Authors:  K A Papadakis; S R Targan
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

6.  Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease.

Authors:  A Woywodt; D Ludwig; P Neustock; A Kruse; K Schwarting; G Jantschek; H Kirchner; E F Stange
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-03       Impact factor: 2.566

7.  Systemic and local cytokine production in quiescent ulcerative colitis and its relationship to future relapse: a prospective pilot study.

Authors:  Takayuki Yamamoto; Satoru Umegae; Tatsushi Kitagawa; Koichi Matsumoto
Journal:  Inflamm Bowel Dis       Date:  2005-06       Impact factor: 5.325

8.  Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation.

Authors:  L Mazzucchelli; C Hauser; K Zgraggen; H Wagner; M Hess; J A Laissue; C Mueller
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

9.  Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis.

Authors:  Y R Mahida; M Ceska; F Effenberger; L Kurlak; I Lindley; C J Hawkey
Journal:  Clin Sci (Lond)       Date:  1992-03       Impact factor: 6.124

10.  Butyrate inhibits leukocyte adhesion to endothelial cells via modulation of VCAM-1.

Authors:  Thomas Menzel; Hardi Lührs; Sabine Zirlik; Jürgen Schauber; Theodor Kudlich; Tobias Gerke; Andrea Gostner; Manfred Neumann; Ralph Melcher; Wolfgang Scheppach
Journal:  Inflamm Bowel Dis       Date:  2004-03       Impact factor: 5.325

View more
  19 in total

1.  Randomized controlled trial: moxibustion and acupuncture for the treatment of Crohn's disease.

Authors:  Chun-Hui Bao; Ji-Meng Zhao; Hui-Rong Liu; Yuan Lu; Yi-Fang Zhu; Yin Shi; Zhi-Jun Weng; Hui Feng; Xin Guan; Jing Li; Wei-Feng Chen; Lu-Yi Wu; Xiao-Ming Jin; Chuan-Zi Dou; Huan-Gan Wu
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Moxibustion inhibits apoptosis and tumor necrosis factor-alpha/tumor necrosis factor receptor 1 in the colonic epithelium of Crohn's disease model rats.

Authors:  Chun-Hui Bao; Lu-Yi Wu; Huan-Gan Wu; Yin Shi; Hui-Rong Liu; Rong Zhang; Li-Qing Yu; Jin-Hai Wang
Journal:  Dig Dis Sci       Date:  2012-04-25       Impact factor: 3.199

3.  Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.

Authors:  Qin Qi; Ya-Nan Liu; Xiao-Ming Jin; Lin-Shuang Zhang; Cun Wang; Chun-Hui Bao; Hui-Rong Liu; Huan-Gan Wu; Xiao-Mei Wang
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

4.  Moxibustion inhibits interleukin-12 and tumor necrosis factor alpha and modulates intestinal flora in rat with ulcerative colitis.

Authors:  Xiao-Mei Wang; Yuan Lu; Lu-Yi Wu; Shu-Guang Yu; Bai-Xiao Zhao; Hong-Yi Hu; Huan-Gan Wu; Chun-Hui Bao; Hui-Rong Liu; Jin-Hai Wang; Yi Yao; Xue-Gui Hua; Hui-Ying Guo; Li-Rong Shen
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

5.  Moxibustion down-regulates colonic epithelial cell apoptosis and repairs tight junctions in rats with Crohn's disease.

Authors:  Chun-Hui Bao; Lu-Yi Wu; Yin Shi; Huan-Gan Wu; Hui-Rong Liu; Rong Zhang; Li-Qing Yu; Jin-Hai Wang
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

Review 6.  Moxibustion for ulcerative colitis: a systematic review and meta-analysis.

Authors:  Dong-Hyo Lee; Jong-In Kim; Myeong Soo Lee; Tae-Young Choi; Sun-Mi Choi; Edzard Ernst
Journal:  BMC Gastroenterol       Date:  2010-04-07       Impact factor: 3.067

7.  Moxibustion regulates inflammatory mediators and colonic mucosal barrier in ulcerative colitis rats.

Authors:  Tie-Ming Ma; Na Xu; Xian-De Ma; Zeng-Hua Bai; Xing Tao; Hong-Chi Yan
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

8.  Effects of Moxibustion Stimulation on the Intensity of Infrared Radiation of Tianshu (ST25) Acupoints in Rats with Ulcerative Colitis.

Authors:  Xiaomei Wang; Shuang Zhou; Wei Yao; Hua Wan; Huangan Wu; Luyi Wu; Huirong Liu; Xuegui Hua; Peifeng Shi
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-20       Impact factor: 2.629

9.  Herb-Partitioned Moxibustion Regulates the TLR2/NF-κB Signaling Pathway in a Rat Model of Ulcerative Colitis.

Authors:  Xiaomei Wang; Yanan Liu; Hongsheng Dong; Luyi Wu; Xiaoming Feng; Zhigang Zhou; Chen Zhao; Huirong Liu; Huangan Wu
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-03       Impact factor: 2.629

10.  Moxibustion and Acupuncture Ameliorate Crohn's Disease by Regulating the Balance between Th17 and Treg Cells in the Intestinal Mucosa.

Authors:  Chen Zhao; Chunhui Bao; Jing Li; Yifang Zhu; Siyao Wang; Ling Yang; Yin Shi; Huirong Liu; Chuanzi Dou; Guanghong Ding; Xiaomei Wang; Huangan Wu
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.